Skip to main content
Fig. 2 | Critical Care

Fig. 2

From: Effect of intravenous clarithromycin in patients with sepsis, respiratory and multiple organ dysfunction syndrome: a randomized clinical trial

Fig. 2

Twenty-eight-day survival among trial participants (A) 28-day survival analysis by Kaplan–Meier curves among patients with sepsis and multiple organ dysfunction syndrome, treated with clarithromycin or placebo. Hazard ratio is provided by Cox-regression analysis. (B) Risk of death within 28-days in pre-specified subgroups among patients treated with clarithromycin or placebo. P values for interactions between treatment arm and subgroup are provided by the Breslow–Day test. *Calculated using the Firth correction. ARDS, acute respiratory distress syndrome; CI, confidence intervals; ICU, intensive care unit; SOFA, Sequential Organ Failure Assessment

Back to article page

Critical Care

ISSN: 1364-8535